0000899243-21-003427.txt : 20210126
0000899243-21-003427.hdr.sgml : 20210126
20210126215914
ACCESSION NUMBER: 0000899243-21-003427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20210126
DATE AS OF CHANGE: 20210126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snodgres Jon
CENTRAL INDEX KEY: 0001613498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 21556597
MAIL ADDRESS:
STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET
STREET 2: BUILDING #1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-25
0
0000730272
REPLIGEN CORP
RGEN
0001613498
Snodgres Jon
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Chief Financial Officer
Common Stock
2021-01-25
4
M
0
4000
33.87
A
33498
D
Stock Option (Right to Buy)
33.87
2021-01-25
4
M
0
4000
0.00
D
2028-03-01
Common Stock
4000
6887
D
Shares vest and become exercisable as follows: 6,887 shares on 3/1/2021.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2021-01-26